Entrepreneurship for Cardiovascular Health Opportunities (ECHO) is a 12-month national training program supporting cardiovascular research commercialization through education, mentorship, networking, and funding. Led by a diverse team of experts, ECHO fosters...
The Ted Rogers Centre for Heart Research is thrilled to welcome Dr. Cedric Manlhiot as the inaugural Rogers Innovator of Cardiovascular Precision Medicine at SickKids. In addition to his role at TRCHR, Dr. Manlhiot will be a Scientist in the Translational Medicine...
Entrepreneurship for Cardiovascular Health Opportunities (ECHO) is a 12-month national training program supporting cardiovascular research commercialization through education, mentorship, networking, and funding. Led by a diverse team of experts, ECHO fosters...
Launching in March 2024, emergency department (ED) physicians at the University Health Network (UHN) can now access the Emergency Heart Failure Mortality Risk Grade (EHMRG) calculator within Epic, UHN’s electronic medical record. The EHMRG score estimates the risk of...
Cardiomyopathy is a leading cause of heart failure in children, and there are currently no effective treatments. Could emerging therapies that successfully target the root cause of the condition in adults also work well in children? That was the question Dr....
In the realm of cardiac health, an exciting new study has cast light on the intricate details of our hearts, revealing significant differences between the left and right ventricles' fibroblasts. This research, conducted by a team of dedicated scientists from the...
Director, Pediatric Electrophysiology, St. Louis Children’s Hospital
Faculty Fellow in Entrepreneurship, Washington University in St. Louis
Professor, Pediatrics and Biomedical Engineering, Washington University in St. Louis
Co-Founder & Chief Medical Officer, Sentiar, Inc.
Co-Founder & Consultant, Excera, Inc.
Jennifer Silva is Director of Pediatric Electrophysiology and a Professor of Pediatrics and Biomedical Engineering at Washington University School of Medicine/St. Louis Children’s Hospital, and serves as the Faculty Fellow in Entrepreneurship for Washington University SOM. She serves in leadership roles within the Heart Rhythm Society (leadership roles in Women in Electrophysiology, Growth and Leadership Opportunity for Women in Electrophysiology, HRX, Digital Health Committee), Pediatric and Congenital Electrophysiology Society (President), American College of Cardiology (leadership roles on the Innovation Council, Industry Advisory Forum, Applied Health and Innovation Council) and the NIH-SBIR study section for Cardiovascular Innovation. She is a Senior Member of the National Academy of Inventors and serves on the Editorial Boards of numerous journals including Circulation: Arrhythmia and Electrophysiology, Heart Rhythm O2, and Cardiovascular Digital Health journals.
The scope of her research has been in innovation and emerging technologies with on developing and identifying clinical applications of new and emerging technologies within cardiac electrophysiology, particularly in the scope of wearable and advanced wearable technologies, including the extended realities.
Jennifer is the co-inventor and co-founder of SentiAR, Inc, a venture-backed software device spinout from Washington University which is developing the first mixed reality platform to display intraprocedural 3-dimensional holographic visualization of a patient’s cardiac anatomy with real time catheter locations for cardiac electrophysiology studies with FDA clearance in 2020. In 2018, the company received a NIH-SBIR Fast Track award, and has raised >$10M in venture funding. Most recently, she has co-founded a second company, Excera, Inc. which aims to improve outcomes for ultrasound-guided minimally invasive procedures. She has worked with several medical device companies including AliveCor, St Jude Medical/Abbott, Medtronic and Biosense Webster regarding development and implementation of novel technologies targeted to unmet clinical needs and development of regulatory pathways.
Scientific Lead, Cardiac Precision Medicine Program
Dr. Seema Mital is a Heart Failure and Transplant Cardiologist and Head of Cardiovascular Research at the Hospital for Sick Children, Toronto. She is Professor of Pediatrics at the University of Toronto and a Senior Scientist at the SickKids Research Institute. She is also the Heart and Stroke Foundation of Canada / Robert M Freedom Chair of Cardiovascular Science, and Scientific Lead of the Ted Rogers Centre for Heart Research. Mital has a strong translational research program focused on genomics, pharmacogenomics and stem cell applications to model childhood heart disease and discover new therapies. She has extensive experience in the genetics/genomics of congenital heart disease and heart failure, personalized medicine and clinical trials. She established the SickKids Heart Centre Biobank, a multi-centre biorepository of children and adults with childhood onset heart disease for genomics research, one of the largest international repositories of its kind. Mital is the Principal Investigator of the CIHR-funded INSERT-HCM multi-centre project aimed at implementing digital health technology, the NIH-funded Pediatric Heart Network for clinical trials, and leads the international ERAPerMed funded PROCEED network for Personalized Genomics in congenital heart disease.